Immune evasion in renal cell carcinoma: biology, clinical translation, future directions

This article reviews the current understanding of the different, yet coordinated, mechanisms adopted by RCC cells to evade immune killing; summarizes various aspects of clinical translation thus far, including the currently registered RCC clinical trials exploring agents in combination with checkpoint inhibitors; and provides perspectives on the current landscape and future directions for the field.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: review Source Type: research